These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17445941)

  • 1. Do not trivialize the Fibroscan examination, value its accuracy.
    Rigamonti C; Fraquelli M
    J Hepatol; 2007 Jun; 46(6):1149. PubMed ID: 17445941
    [No Abstract]   [Full Text] [Related]  

  • 2. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients.
    Kettaneh A; Marcellin P; Douvin C; Poupon R; Ziol M; Beaugrand M; de Lédinghen V
    J Hepatol; 2007 Apr; 46(4):628-34. PubMed ID: 17258346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
    Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M
    J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FibroScan evaluation of liver fibrosis in liver transplantation.
    Sánchez Antolin G; Garcia Pajares F; Vallecillo MA; Fernandez Orcajo P; Gómez de la Cuesta S; Alcaide N; Gonzalez Sagrado M; Velicia R; Caro-Patón A
    Transplant Proc; 2009 Apr; 41(3):1044-6. PubMed ID: 19376422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating the applicability rate into the performance evaluation of noninvasive staging of liver fibrosis: a step towards a change from the "accuracy" to the "clinical" paradigm.
    Carrat F
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):691-2. PubMed ID: 22115610
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
    Macías J; Recio E; Vispo E; Rivero A; López-Cortés LF; Ríos MJ; Merino D; González M; Barreiro P; de Lédinghen V; Quereda C; Pineda JA
    J Hepatol; 2008 Dec; 49(6):916-22. PubMed ID: 18929426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease.
    Alisi A; Pinzani M; Nobili V
    Hepatology; 2009 Dec; 50(6):2048-9; author reply 2049-50. PubMed ID: 19937689
    [No Abstract]   [Full Text] [Related]  

  • 10. Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis.
    Afdhal NH; Curry M
    J Hepatol; 2007 Apr; 46(4):543-5. PubMed ID: 17316879
    [No Abstract]   [Full Text] [Related]  

  • 11. The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs.
    Nguyen-Khac E; Capron D; Braillon A; Dupas JL
    Gut; 2008 Nov; 57(11):1630; author reply 1630-1. PubMed ID: 18941012
    [No Abstract]   [Full Text] [Related]  

  • 12. [Using non-invasive transient elastography for the assessment of hepatic fibrosis].
    Luo JW; Shao JH; Bai J; Cui LG; Wang JR
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):395-7. PubMed ID: 16732926
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
    Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.
    Takemoto R; Nakamuta M; Aoyagi Y; Fujino T; Yasutake K; Koga K; Yoshimoto T; Miyahara T; Fukuizumi K; Wada Y; Takami Y; Saitsu H; Harada N; Nakashima M; Enjoji M
    J Dig Dis; 2009 May; 10(2):145-8. PubMed ID: 19426398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
    Chavez-Tapia NC; Tiribelli C
    Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Noninvasive diagnosis of fatty liver disease].
    Qu Y; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):155-7. PubMed ID: 20196962
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.
    Vergara S; Macías J; Rivero A; Gutiérrez-Valencia A; González-Serrano M; Merino D; Ríos MJ; García-García JA; Camacho A; López-Cortés L; Ruiz J; de la Torre J; Viciana P; Pineda JA;
    Clin Infect Dis; 2007 Oct; 45(8):969-74. PubMed ID: 17879910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative studies on the influence of connective tissue and fatty structures on the ultrasonic image of the liver].
    Haberkorn U; Zuna I; Zerban H; Layer G; Lorenz A; van Kaick G; Räth U
    Rofo; 1989 Oct; 151(4):439-42. PubMed ID: 2554381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.